Meet 22nd Century Group, the biotech co. driven by the mission to reduce the harm caused by smoking.
Headquartered in Buffalo, New York, 22nd Century Group is a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research.
MOCKSVILLE, N.C.,, June 26, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice ...
Combined Cumulative Value of New License and Distribution Agreements Executed to Date Expected to Exceed $140 Million Over Contract Terms BUFFALO, N.Y., May 02, 2023 (GLOBE NEWSWIRE) -- 22nd Century ...
MOCKSVILLE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a ...
22nd Century Group, Inc. (XXII) is one of the most interesting stocks in biotechnology right now. The company, which bills itself as a biotechnology company and is based in New York, has developed a ...
22nd Century developed SPECTRUM® research cigarettes in partnership with independent researchers and officials from the National Institute on Drug Abuse (NIDA), the U.S. Food and Drug Administration ...
Management now expects profitability to be achieved in the first half of 2026, later than previously indicated. Otto said, "we now expect the impact of delays in the time necessary to execute the ...
22nd Century Group is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption. We created our flagship product, the VLN ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results